These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7937285)

  • 21. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients.
    Taylor PJ; Kubler PA; Lynch SV; Allen J; Butler M; Pillans PI
    Ann Pharmacother; 2004 Feb; 38(2):205-8. PubMed ID: 14742751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium antagonists in heart transplant recipients: effects on cardiac and renal function and cyclosporine pharmacokinetics.
    Legault L; Ogilvie RI; Cardella CJ; Leenen FH
    Can J Cardiol; 1993 Jun; 9(5):398-404. PubMed ID: 8348391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study.
    Ingsathit A; Sumethkul V; Chalermsanyakorn P; Jirasiritham S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S235-41. PubMed ID: 17044477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of isradipine on renal hemodynamics in renal transplant patients treated with cyclosporine.
    Ahmed K; Michael B; Burke JF
    Clin Nephrol; 1997 Nov; 48(5):307-10. PubMed ID: 9403215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation of diltiazem affects cyclosporin-sparing activity.
    Jones TE; Morris RG; Mathew TH
    Eur J Clin Pharmacol; 1997; 52(1):55-8. PubMed ID: 9143868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FTY720 and cyclosporine: evaluation for a pharmacokinetic interaction.
    Kovarik JM; Schmouder RL; Barilla D; Büche M; Rouilly M; Berthier S; Wang Y; Van Saders C; Mayer T; Gottlieb AB
    Ann Pharmacother; 2004; 38(7-8):1153-8. PubMed ID: 15138297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR; Egan JM; Dickinson TH; Carrum G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients.
    Bleck JS; Thiesemann C; Kliem V; Christians U; Hecker H; Repp H; Frei U; Westhoff-Bleck M; Manns M; Sewing KF
    Br J Clin Pharmacol; 1996 Jun; 41(6):551-6. PubMed ID: 8799521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone-cyclosporine interaction in a heart transplant patient.
    Nicolau DP; Uber WE; Crumbley AJ; Strange C
    J Heart Lung Transplant; 1992; 11(3 Pt 1):564-8. PubMed ID: 1610865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interactions of digoxin with nifedipine and diltiazem].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):467-9. PubMed ID: 2277790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketoconazole inhibits cyclosporine metabolism in vivo in mice.
    Anderson JE; Blaschke TF
    J Pharmacol Exp Ther; 1986 Mar; 236(3):671-4. PubMed ID: 3950868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rifampin and ansamycin interactions with cyclosporine after renal transplantation.
    Vandevelde C; Chang A; Andrews D; Riggs W; Jewesson P
    Pharmacotherapy; 1991; 11(1):88-9. PubMed ID: 2020617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic interactions between microemulsion formulated cyclosporine A and diltiazem in renal transplant recipients.
    Asberg A; Christensen H; Hartmann A; Carlson E; Molden E; Berg KJ
    Eur J Clin Pharmacol; 1999 Jul; 55(5):383-7. PubMed ID: 10456488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diltiazem-cyclosporin pharmacokinetic interaction--dose-response relationship.
    Jones TE; Morris RG; Mathew TH
    Br J Clin Pharmacol; 1997 Nov; 44(5):499-504. PubMed ID: 9384468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach.
    McLachlan AJ; Tett SE
    Ther Drug Monit; 1998 Aug; 20(4):390-5. PubMed ID: 9712463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.